跳至內容

2-氨基-5-甲氧基茚滿

維基百科,自由的百科全書
2-氨基-5-甲氧基茚滿
臨床資料
商品名英語Drug nomenclaturenone
其他名稱5-MeO-AI; 2,3-Dihydro-5-methoxy-1H-Inden-2-amine
給藥途徑Oral
法律規範狀態
法律規範
  • NpSG
  • PSA
  • Unscheduled
藥物動力學數據
生物利用度high
藥物代謝acetyl-aminoindandane
生物半衰期non-linear
排泄途徑full
識別資訊
  • 5-Methoxy-2-aminoindane
CAS號73305-09-6  checkY
PubChem CID
ChemSpider
UNII
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
化學資訊
化學式C10H13NO
摩爾質量163.22 g·mol−1
3D模型(JSmol英語JSmol
  • COC1=CC2=C(CC(C2)N)C=C1
  • InChI=1S/C10H13NO/c1-12-10-3-2-7-4-9(11)5-8(7)6-10/h2-3,6,9H,4-5,11H2,1H3
  • Key:HLXHCNWEVQNNKA-UHFFFAOYSA-N

2-氨基-5-甲氧基茚滿是一種有機化合物,化學式為C10H13NO。它是一種消遣性藥物和預防酗酒的藥物,最初於1998年在專利中以Markush結構被隱匿提及。[1]它可以5-甲氧基茚滿-2-酮[2]或5-溴茚滿-2-醇[3]為原料製得。它和鹽酸反應,可以得到2-氨基-5-甲氧基茚滿鹽酸鹽。[4]

參考文獻

[編輯]
  1. ^ US 5708018,Haadsma-Svensson, Susanne R.; Bengt R. Andersson & Clas A. Sonesson et al.,「2-aminoindans as selective dopamine D3 ligands」,發表於1998-01-13,指定於Pharmacia & Upjohn Co. 
  2. ^ Renhowe, Paul A.; Chu, Daniel; Boyce, Rustum; Ni, Zhi-jie; Duhl, David; Tozzo, Effie; Johnson, Kirk; Myles, David. Preparation of guanidinobenzamides as melanocortin-4 receptor agonists useful for treating diseases such obesity and type II diabetes. 2002 WO 2002018327 A2.
  3. ^ Yusuf Akbaba, Süleyman Göksu, Ertan Şahin, Hamdullah Kılıç, Hasan Seçen. Synthesis and asymmetric resolution of a dopaminergic compound: 2-amino-5-methoxyindane. Tetrahedron: Asymmetry. 2016-07, 27 (11-12): 475–479 [2022-08-03]. doi:10.1016/j.tetasy.2016.04.005. (原始內容存檔於2022-02-16) (英語). 
  4. ^ Chen, Xiaoli; Demarest, Keith T.; Lee, Jung; Matthews, Jay M.; Rybczynski, Philip. Preparation of substituted indanes and tetralins as PPARα modulators for treating Syndrome X. 2006 US 20060094786 A1.